Albendazole for the treatment of human echinococcosis: A review of comparative clinical trials

American Journal of the Medical Sciences

Volumn 334, Issue 3, 2007, Pages 171-179

  Falagas, Matthew E ^a,b,c   Bliziotis, Ioannis A ^a  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b HENRY DUNANT HOSPITAL   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Benzimidazoles; Echinococciasis; Echinococcus granulosus; Hydatid cyst; Mebendazole; PAIR; Percutaneous therapy; Praziquantel; Surgical therapy

Indexed keywords

ALBENDAZOLE; BENZIMIDAZOLE DERIVATIVE; FLUBENDAZOLE; MEBENDAZOLE; PLACEBO; PRAZIQUANTEL; SCOLICIDAL AGENT; UNCLASSIFIED DRUG;

ABDOMINAL SURGERY; ADJUVANT THERAPY; ASPIRATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; COUGHING; CYST RUPTURE; DRUG EFFICACY; DRUG MECHANISM; DRUG WITHDRAWAL; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; FEVER; FOLLOW UP; HEMOPTYSIS; HUMAN; HYDATID CYST; INTERMETHOD COMPARISON; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PATIENT COMPLIANCE; PREOPERATIVE TREATMENT; PUNCTURE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; ULTRASOUND; UNSPECIFIED SIDE EFFECT; URTICARIA;

EID: 34548666405     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31814252f8     Document Type: Article

References (42)

1. Budke CM, Qiu JM, Zinsstag J, et al. Use of disability adjusted life years in the estimation of the disease burden of echinococcosis for a high endemic region of the Tibetan plateau. Am J Trop Med Hyg 2004;71:56-64.
2. Atmatzidis KS, Pavlidis TE, Papaziogas BT, et al. Recurrence and long-term outcome after open cystectomy with omentoplasty for hepatic hydatid disease in an endemic area. Acta Chir Belg 2005;105:198-202.
3. Yorganci K, Sayek I. Surgical treatment of hydatid cysts of the liver in the era of percutaneous treatment. Am J Surg 2002;184:63-9.
4. El On J. Benzimidazole treatment of cystic echinococcosis. Acta Trop 2003;85:243-52.
5. Schipper HG, Kager PA. Diagnosis and treatment of hepatic echinococcosis: an overview. Scand J Gastroenterol Suppl 2004;241:50-5.
6. Saimot AG. Medical treatment of liver hydatidosis. World J Surg 2001;25:15-20.
7. Yasawy MI, Alkarawi MA, Mohammed ARE. Prospects in medical management of Echinococcus granulosus. Hepato-Gastroenterology 2001;48:1467-70.
8. Horton J. Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations. Curr Opin Infect Dis 2002;15:599-608.
9. Horton RJ. Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Tropica 1997;64:79-93.
10. Opatrny L, Prichard R, Snell L, et al. Death related to albendazole-induced pancytopenia: case report and review. Am J Trop Med Hyg 2005;72:291-294.
11. Rosenblatt JE. Antiparasitic agents. Mayo Clin Proc 1999;74:1161-75.
12. Reynoldson JA, Thompson RCA, Horton RJ. Albendazole as a future antigiardial agent. Parasitol Today 1992;8:411-2.
13. Dziri C, Haouet K, Fingerhut A. Treatment of hydatid cyst of the liver: where is the evidence? World J Surg 2004;28:731-6.
14. Dziri C, Haouet K, Zaouche A, et al. [How to treat an uncomplicated hydatid liver cyst?]. Ann Chir 2005;130:249-51.
15. Keshmiri M, Baharvahdat H, Fattahi SH, et al. Albendazole versus placebo in treatment of echinococcosis. Trans R Soc Trop Med Hyg 2001;95:190-4.
16. Davis A, Pawlowski ZS, Dixon H. Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis. Bull World Health Organ 1986;64:383-8.
17. Davis A, Dixon H, Pawlowski ZS. Multicentre clinical trials of benzimidazole-carbamates in human cystic echinococcosis (phase 2). Bull World Health Organ 1989;67:503-8.
18. Todorov T, Vutova K, Mechkov G, et al. Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole. Ann Trop Med Parasitol 1992;86:59-66.
19. Franchi C, Di Vico B, Teggi A. Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates. Clin Infect Dis 1999;29:304-9.
20. Yasawy MI, Alkarawi MA, Mohamed ARE. Combination of praziquantel and albendazole in the treatment of hydatid-disease. Trop Med Parasitol 1993;44:192-4.
21. Casado N, Urrea-Paris MA, Moreno MJ, et al. Combined praziquantel and albendazole chemoprophylaxis in experimental hydatidosis. Parasitol Res 2001;87:787-9.
22. Moreno MJ, Urrea-Paris MA, Casado N, et al. Praziquantel and albendazole in the combined treatment of experimental hydatid disease. Parasitol Res 2001;87:235-8.
23. Urrea-Paris MA, Moreno MJ, Casado N, et al. In vitro effect of praziquantel and albendazole combination therapy on the larval stage of Echinococcus granulosus. Parasitol Res 2000;86:957-64.
24. Ayles HM, Corbett EL, Taylor I, et al. A combined medical and surgical approach to hydatid disease: 12 years' experience at the Hospital for Tropical Diseases, London. Ann R Coll Surgeons England 2002;84:100-5.
25. Cobo F, Yarnoz C, Sesma B, et al. Albendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatidosis caused by Echinococcus granulosus. Trop Med Int Health 1998;3:462-6.
26. Mohamed AE, Yasawy MI, Al Karawi MA. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. Hepatogastroenterology 1998;45:1690-4.
27. Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG, et al. Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 1993;342:1269-72.
28. Wen H, Zou PF, Yang WG, et al. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China. Trans R Soc Trop Med Hyg 1994;88:340-3.
29. Aktan AO, Yalin R. Preoperative albendazole treatment for liver hydatid disease decreases the viability of the cyst. Eur J Gastroenterol Hepatol 1996;8:877-9.
30. Stankovic N, Ignjatovic M, Nozic D, et al. Liver hydatid disease: morphological changes of protoscoleces after albendazole therapy. Vojnosanit Pregl 2005;62:175-9.
31. Khuroo MS, Dar MY, Yattoo GN, et al. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology 1993;104:1452-9.
32. Khuroo MS, Wani NA, Javid G, et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med 1997;337:881-7.
33. Larrieu EJ, Frider B. Human cystic echinococcosis: contributions to the natural history of the disease. Ann Trop Med Parasitol 2001;95:679-87.
34. Macpherson CN, Bartholomot B, Frider B. Application of ultrasound in diagnosis, treatment, epidemiology, public health and control of Echinococcus granulosus and E. multilocularis. Parasitology 2003;127(Suppl):S21-35.
35. Frider B, Larrieu E, Odriozola M. Long-term outcome of asymptomatic liver hydatidosis. J Hepatol 1999;30:228-31.
36. Larrieu E, Frider B, del Carpio M, et al. [Asymptomatic carriers of hydatidosis: epidemiology, diagnosis, and treatment]. Rev Panam Salud Publica 2000;8:250-6.
37. WHO, OIE Echinococcosis in humans: clinical aspects, diagnosis and treatment. In: Eckert J, Gemmell MA, Meslin FX, Pawlowski ZS, editors. WHO/OIE Manual on echinococcosis in humans and animals. Paris: 2001; p. 47.
38. Casado N, Urrea-Paris MA, Moreno MJ, et al. Combined praziquantel and albendazole chemoprophylaxis in experimental hydatidosis. Parasitol Res 2001;87:787-9.
39. Moreno MJ, Urrea-Paris MA, Casado N, et al. Praziquantel and albendazole in the combined treatment of experimental hydatid disease. Parasitol Res 2001;87:235-8.
40. Urrea-Paris MA, Moreno MJ, Casado N, et al. In vitro effect of praziquantel and albendazole combination therapy on the larval stage of Echinococcus granulosus. Parasitol Res 2000;86:957-64.
41. Vutova K, Mechkov G, Vachkov P, et al. Effect of mebendazole on human cystic echinococcosis: the role of dosage and treatment duration. Ann Trop Med Parasitol 1999;93:357-65.
42. Rippmann K, Dietrich M, Kern P. [Long-term therapy of cystic liver echinococcosis with mebendazole.] Med Klin (Munich) 1992;87:350-4.